<code id='AB7B4216CA'></code><style id='AB7B4216CA'></style>
    • <acronym id='AB7B4216CA'></acronym>
      <center id='AB7B4216CA'><center id='AB7B4216CA'><tfoot id='AB7B4216CA'></tfoot></center><abbr id='AB7B4216CA'><dir id='AB7B4216CA'><tfoot id='AB7B4216CA'></tfoot><noframes id='AB7B4216CA'>

    • <optgroup id='AB7B4216CA'><strike id='AB7B4216CA'><sup id='AB7B4216CA'></sup></strike><code id='AB7B4216CA'></code></optgroup>
        1. <b id='AB7B4216CA'><label id='AB7B4216CA'><select id='AB7B4216CA'><dt id='AB7B4216CA'><span id='AB7B4216CA'></span></dt></select></label></b><u id='AB7B4216CA'></u>
          <i id='AB7B4216CA'><strike id='AB7B4216CA'><tt id='AB7B4216CA'><pre id='AB7B4216CA'></pre></tt></strike></i>

          Home / entertainment / hotspot

          hotspot


          hotspot

          author:leisure time    Page View:34364
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In